Avantor Investor Day Presentation Deck

LABORATORY SOLUTIONS: Trusted partner enabling scientific insights REVENUE ~$4.7B 2023E ADJ. OPERATING MARGIN ~15% 2023E 2023E revenue based on midpoint of FY 2023 guidance, as of Q3 2023 earnings call. Segment financials based on management estimates for FY 2023. Effective date for the new segment structure is 1/1/24. Comprehensive portfolio of high- quality laboratory consumables, equipment, services and digital solutions NEW OPERATING MODEL Deeply embedded in our customers' laboratory ecosystems Supporting scientific discoveries in regulated environments with high quality standards Navantor™ 18

View entire presentation